30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Catalent Inc (CTLT)

Track

Stock chart
Ticker: CTLT Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Ryan Michelle R
2 sales — total 334,320 USD
Sale 11 Nov 2024
Value US$3,086,008.28 | Price 306.33 | Shares 25,665
Proposed sale 11 Nov 2024
Value US$105,774.97 | Price 430.40 | Shares 91,111
Sale 18 Oct 2024
Value US$2,946,649.59 | Price 265.03 | Shares 86,093
Proposed sale 18 Oct 2024
Value US$1,594,715.06 | Price 409.03 | Shares 49,679
Proposed sale 16 Oct 2024
Value US$37,855.50 | Price 60.57 | Shares 625
Sale 26 Sep 2024
Value US$119,580.18 | Price 59.97 | Shares 1,994
Proposed sale 26 Sep 2024
Value US$130,026.45 | Price 59.98 | Shares 2,168
Proposed sale 5 Aug 2024
Value US$32,674.92 | Price 58.98 | Shares 554
Sale 2 Aug 2024
Value US$39,660.30 | Price 59.55 | Shares 666
Proposed sale 2 Aug 2024
Value US$39,660.50 | Price 59.55 | Shares 666
Sale 2 Aug 2024
Value US$39,428.72 | Price 59.56 | Shares 662
Proposed sale 2 Aug 2024
Value US$39,427.20 | Price 59.56 | Shares 662
Sale 2 Aug 2024
Value US$36,224.64 | Price 59.58 | Shares 608
Proposed sale 2 Aug 2024
Value US$36,225.13 | Price 59.58 | Shares 608
Sale 2 Aug 2024
Value US$69,613.95 | Price 59.55 | Shares 1,169
Proposed sale 2 Aug 2024
Value US$69,609.27 | Price 59.55 | Shares 1,169
Sale 2 Aug 2024
Value US$230,266.53 | Price 59.67 | Shares 3,859
Proposed sale 2 Aug 2024
Value US$230,273.86 | Price 59.12 | Shares 3,895
Proposed sale 2 Aug 2024
Value US$24,648.54 | Price 59.68 | Shares 413
Proposed sale 30 Jul 2024
Value US$13,850.90 | Price 58.94 | Shares 235
Sale 29 Jul 2024
Value US$12,086.02 | Price 58.67 | Shares 206
Proposed sale 29 Jul 2024
Value US$12,086.64 | Price 58.67 | Shares 206
Sale 29 Jul 2024
Value US$534,010.88 | Price 58.76 | Shares 9,088
Proposed sale 29 Jul 2024
Value US$534,033.60 | Price 58.76 | Shares 9,088
Sale 29 Jul 2024
Value US$16,609.27 | Price 58.69 | Shares 283
Proposed sale 29 Jul 2024
Value US$16,608.85 | Price 58.69 | Shares 283
Sale 29 Jul 2024
Value US$20,486.30 | Price 58.70 | Shares 349
Proposed sale 29 Jul 2024
Value US$20,486.86 | Price 58.70 | Shares 349
Proposed sale 29 Jul 2024
Value US$12,766.09 | Price 58.83 | Shares 217
Sale 8 Jul 2024
Value US$169,822.82 | Price 56.74 | Shares 2,993
Proposed sale 8 Jul 2024
Value US$169,815.94 | Price 56.74 | Shares 2,993
Sale 4 Jun 2024
Value US$76,022.60 | Price 54.26 | Shares 1,401
Proposed sale 4 Jun 2024
Value US$76,022.60 | Price 54.26 | Shares 1,401
Proposed sale 13 May 2024
Value US$176,623.91 | Price 55.77 | Shares 3,167
Planned sale 15 Mar 2024
Value US$21,749.40 | Price 56.20 | Shares 387
Proposed sale 15 Mar 2024
Value US$21,749.40 | Price 56.20 | Shares 387
Proposed sale 12 Mar 2024
Value US$303,816.04 | Price 56.51 | Shares 5,376
Buy 31 Aug 2023
Value US$49,980.00 | Price 49.98 | Shares 1,000
Buy 30 Aug 2023
Value US$1,055,040.00 | Price 50.24 | Shares 21,000
Sale 24 Aug 2023
Value US$3,903.69 | Price 44.87 | Shares 87
Proposed sale 24 Aug 2023
Value US$3,903.88 | Price 44.87 | Shares 87
Planned sale 24 Aug 2023
Value US$12,298.56 | Price 44.56 | Shares 276
Proposed sale 24 Aug 2023
Value US$12,298.70 | Price 44.56 | Shares 276
Sale 24 Aug 2023
Value US$17,618.04 | Price 44.49 | Shares 396
Proposed sale 24 Aug 2023
Value US$17,617.45 | Price 44.49 | Shares 396
Sale 24 Aug 2023
Value US$4,560.15 | Price 45.15 | Shares 101
Sale 24 Aug 2023
Value US$87,684.70 | Price 44.51 | Shares 1,970
Proposed sale 24 Aug 2023
Value US$92,247.72 | Price 44.54 | Shares 2,071
Sale 24 Aug 2023
Value US$8,496.80 | Price 44.72 | Shares 190
Proposed sale 24 Aug 2023
Value US$8,496.63 | Price 44.72 | Shares 190
Sale 24 Aug 2023
Value US$6,573.84 | Price 44.72 | Shares 147
Proposed sale 24 Aug 2023
Value US$6,574.21 | Price 44.72 | Shares 147
Sale 24 Aug 2023
Value US$9,657.36 | Price 44.71 | Shares 216
Proposed sale 24 Aug 2023
Value US$9,659.07 | Price 44.72 | Shares 216
Sale 24 Aug 2023
Value US$17,355.00 | Price 44.50 | Shares 390
Proposed sale 24 Aug 2023
Value US$17,355.98 | Price 44.50 | Shares 390
Sale 24 Aug 2023
Value US$11,989.33 | Price 44.57 | Shares 269
Proposed sale 24 Aug 2023
Value US$11,988.60 | Price 44.57 | Shares 269
Sale 24 Aug 2023
Value US$4,745.62 | Price 44.77 | Shares 106
Proposed sale 24 Aug 2023
Value US$4,745.61 | Price 44.77 | Shares 106
Sale 24 Aug 2023
Value US$16,854.13 | Price 44.47 | Shares 379
Proposed sale 24 Aug 2023
Value US$16,854.77 | Price 44.47 | Shares 379
Planned sale 24 Aug 2023
Value US$36,479.05 | Price 44.65 | Shares 817
Proposed sale 24 Aug 2023
Value US$36,482.81 | Price 44.65 | Shares 817
Sale 1 Aug 2023
Value US$25,026.24 | Price 47.76 | Shares 524
Sale 1 Aug 2023
Value US$51,999.36 | Price 46.72 | Shares 1,113
Sale 1 Aug 2023
Value US$6,466.50 | Price 47.90 | Shares 135
Sale 1 Aug 2023
Value US$2,963.60 | Price 47.80 | Shares 62
Sale 1 Aug 2023
Value US$7,719.95 | Price 47.95 | Shares 161
Sale 1 Aug 2023
Value US$10,607.16 | Price 47.78 | Shares 222
Sale 1 Aug 2023
Value US$2,185.50 | Price 46.50 | Shares 47
Sale 1 Aug 2023
Value US$10,531.40 | Price 47.87 | Shares 220
Sale 1 Aug 2023
Value US$2,841.38 | Price 46.58 | Shares 61
Sale 1 Aug 2023
Value US$12,376.26 | Price 47.97 | Shares 258
Sale 1 Aug 2023
Value US$9,101.00 | Price 47.90 | Shares 190
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-14 2024-11-11 S Sale
1.6
Ryan Michelle R
Non-Executive Director
25,665 +4.7%
306.33
US$3,086,008 		25,665 +4.7% 306.33 US$3,086,008
2024-11-12 2024-11-11 PrS Proposed sale
1.6
Ryan Michelle R

Director

Non-Executive Director
91,111
430.40
US$105,775 		91,111 430.40 US$105,775
2024-10-21 2024-10-18 S Sale
2.2
Ferraro Joseph Anthony

SVP, General Counsel, CCO

Officer
86,093 +24.4%
265.03
US$2,946,650 		86,093 +24.4% 265.03 US$2,946,650
2024-10-18 2024-10-18 PrS Proposed sale
2.2
Ferraro Joseph Anthony

Officer

Officer
320
59.97
US$19,191 		320 59.97 US$19,191
2024-10-16 2024-10-16 PrS Proposed sale
3.9
Hawkeswood Thomas W

Officer

Officer
625
60.57
US$37,856 		625 60.57 US$37,856
2024-09-27 2024-09-26 S Sale
2.1
McErlane David

Group President, Biologics

Officer
1,994 -5.2%
59.97
US$119,580 		1,994 -5.2% 59.97 US$119,580
2024-09-26 2024-09-26 PrS Proposed sale
2.1
McErlane David

Officer

Officer
2,168
59.98
US$130,026 		2,168 59.98 US$130,026
2024-08-05 2024-08-05 PrS Proposed sale
3.9
Gunther Scott

Officer

Officer
554
58.98
US$32,675 		554 58.98 US$32,675
2024-08-05 2024-08-02 S Sale
3.9
Gunther Scott

SVP, Quality & Reg. Affairs

Officer
666 -1.7%
59.55
US$39,660 		666 -1.7% 59.55 US$39,660
2024-08-05 2024-08-02 S Sale
3.7
Hopson Ricky

Pres. BioProduct Delivery, CoS

Officer
662 -2.2%
59.56
US$39,429 		662 -2.2% 59.56 US$39,429
2024-08-05 2024-08-02 S Sale
2.2
Ferraro Joseph Anthony

SVP, General Counsel, CCO

Officer
608 -2.4%
59.58
US$36,225 		608 -2.4% 59.58 US$36,225
2024-08-05 2024-08-02 S Sale
3.9
Gennadios Aristippos

Group Pres. Pharma & Consumer

Officer
1,169 -1.0%
59.55
US$69,614 		1,169 -1.0% 59.55 US$69,614
2024-08-05 2024-08-02 S Sale
3.4
Evoli Lisa

SVP, Chief HR Officer

Officer
3,859 -8.9%
59.67
US$230,267 		3,859 -8.9% 59.67 US$230,267
2024-08-02 2024-08-02 PrS Proposed sale
3.4
Evoli Lisa

Officer

Officer
3,895
59.12
US$230,274 		3,895 59.12 US$230,274
2024-08-02 2024-08-02 PrS Proposed sale
3.9
Gunther Scott

Officer

Officer
666
59.55
US$39,660 		666 59.55 US$39,660
2024-08-02 2024-08-02 PrS Proposed sale
3.7
Hopson Ricky

Officer

Officer
662
59.56
US$39,427 		662 59.56 US$39,427
2024-08-02 2024-08-02 PrS Proposed sale
3.9
Gennadios Aristippos

Officer

Officer
1,169
59.55
US$69,609 		1,169 59.55 US$69,609
2024-08-02 2024-08-02 PrS Proposed sale
3.9
Hawkeswood Thomas W

Officer

Officer
413
59.68
US$24,649 		413 59.68 US$24,649
2024-08-02 2024-08-02 PrS Proposed sale
2.2
Ferraro Joseph Anthony

Officer

Officer
608
59.58
US$36,225 		608 59.58 US$36,225
2024-07-30 2024-07-30 PrS Proposed sale
3.9
Gunther Scott

Officer

Officer
235
58.94
US$13,851 		235 58.94 US$13,851
2024-07-30 2024-07-29 S Sale
3.7
Hopson Ricky

Pres. BioProduct Delivery, CoS

Officer
206 -0.7%
58.67
US$12,086 		206 -0.7% 58.67 US$12,086
2024-07-30 2024-07-29 S Sale
3.6
Maselli Alessandro

President & CEO

Executive Director
9,088 -4.9%
58.76
US$534,011 		9,088 -4.9% 58.76 US$534,011
2024-07-30 2024-07-29 S Sale
3.9
Gunther Scott

SVP, Quality & Reg. Affairs

Officer
283 -0.7%
58.69
US$16,609 		283 -0.7% 58.69 US$16,609
2024-07-30 2024-07-29 S Sale
3.9
Gennadios Aristippos

Group Pres. Pharma & Consumer

Officer
349 -0.3%
58.70
US$20,486 		349 -0.3% 58.70 US$20,486
2024-07-29 2024-07-29 PrS Proposed sale
3.9
Hawkeswood Thomas W

Officer

Officer
217
58.83
US$12,766 		217 58.83 US$12,766
2024-07-29 2024-07-29 PrS Proposed sale
3.9
Gennadios Aristippos

Officer

Officer
349
58.70
US$20,487 		349 58.70 US$20,487
2024-07-29 2024-07-29 PrS Proposed sale
3.7
Hopson Ricky

Officer

Officer
206
58.67
US$12,087 		206 58.67 US$12,087
2024-07-29 2024-07-29 PrS Proposed sale
3.6
Maselli Alessandro

Officer; Director

Executive Director
9,088
58.76
US$534,034 		9,088 58.76 US$534,034
2024-07-29 2024-07-29 PrS Proposed sale
3.9
Gunther Scott

Officer

Officer
283
58.69
US$16,609 		283 58.69 US$16,609
2024-07-10 2024-07-08 S Sale
0.9
Masanovich Matti

SVP, Chief Financial Officer

Officer
2,993 -8.1%
56.74
US$169,823 		2,993 -8.1% 56.74 US$169,823
2024-07-08 2024-07-08 PrS Proposed sale
0.9
Masanovich Matti

Officer

Officer
2,993
56.74
US$169,816 		2,993 56.74 US$169,816
2024-06-05 2024-06-04 S Sale
3.7
Hopson Ricky

Pres. BioProduct Delivery, CoS

Officer
1,401 -6.4%
54.26
US$76,023 		1,401 -6.4% 54.26 US$76,023
2024-06-04 2024-06-04 PrS Proposed sale
3.7
Hopson Ricky

Officer

Officer
1,401
54.26
US$76,023 		1,401 54.26 US$76,023
2024-05-13 2024-05-13 PrS Proposed sale
Crane Rosemary A

Former Director

Non-Executive Director
3,167
55.77
US$176,624 		3,167 55.77 US$176,624
2024-03-19 2024-03-15 PlS Planned sale
3.9
Gunther Scott

SVP, Quality & Reg. Affairs

Officer
387 -1.3%
56.20
US$21,749 		387 -1.3% 56.20 US$21,749
2024-03-15 2024-03-15 PrS Proposed sale
3.9
Gunther Scott

Officer

Officer
387
56.20
US$21,749 		387 56.20 US$21,749
2024-03-12 2024-03-12 PrS Proposed sale
ROSEMARY CRANE

Director

Non-Executive Director
5,376
56.51
US$303,816 		5,376 56.51 US$303,816
2023-09-05 2023-08-31 B Purchase
1.6
Ryan Michelle R
Non-Executive Director
1,000 +102.1%
49.98
US$49,980 		1,000 +102.1% 49.98 US$49,980
2023-09-01 2023-08-30 B Purchase
3.1
GREISCH JOHN J

Executive Chair

Executive Director
21,000 +161.5%
50.24
US$1,055,040 		21,000 +161.5% 50.24 US$1,055,040
2023-08-25 2023-08-24 S Sale
4.1
Arnold Jonathan

SVP, CCO & Div. Head BioP Del.

Officer
87 -0.2%
44.87
US$3,904 		87 -0.2% 44.87 US$3,904
2023-08-25 2023-08-24 PlS Planned sale
3.7
Hopson Ricky

Pres. Clinical Dev Supply Div

Officer
276 -1.2%
44.56
US$12,299 		276 -1.2% 44.56 US$12,299
2023-08-25 2023-08-24 S Sale
3.9
Gennadios Aristippos

Group Pres. Pharma & Consumer

Officer
396 -0.4%
44.49
US$17,618 		396 -0.4% 44.49 US$17,618
2023-08-25 2023-08-24 S Sale
3.6
Maselli Alessandro

President & CEO

Executive Director
101 -0.1%
45.15
US$4,560 		101 -0.1% 45.15 US$4,560
2023-08-25 2023-08-24 S Sale
3.6
Maselli Alessandro

President & CEO

Executive Director
1,970 -2.2%
44.51
US$87,685 		1,970 -2.2% 44.51 US$87,685
2023-08-25 2023-08-24 S Sale
2.6
Lickfold Charles

SVP, CIO

Officer
190 -1.6%
44.72
US$8,497 		190 -1.6% 44.72 US$8,497
2023-08-25 2023-08-24 S Sale
3.9
Hawkeswood Thomas W

Pres. Pharma Prod Delivery Div

Officer
147 -1.9%
44.72
US$6,574 		147 -1.9% 44.72 US$6,574
2023-08-25 2023-08-24 S Sale
4.1
Carletti Lorenzo

SVP Global Ops Ph & Cons Hlth

Officer
216 -2.4%
44.71
US$9,657 		216 -2.4% 44.71 US$9,657
2023-08-25 2023-08-24 S Sale
3.7
Grippo Michael J

SVP, Strategy & Corp. Dev.

Officer
390 -1.6%
44.50
US$17,355 		390 -1.6% 44.50 US$17,355
2023-08-25 2023-08-24 S Sale
3.9
Gunther Scott

SVP, Quality & Reg. Affairs

Officer
269 -0.9%
44.57
US$11,989 		269 -0.9% 44.57 US$11,989
2023-08-25 2023-08-24 S Sale
3.9
Hunt Patricia

Pres. Consumer Health Div

Officer
106 -0.9%
44.77
US$4,746 		106 -0.9% 44.77 US$4,746
2023-08-25 2023-08-24 S Sale
3.9
Pravda Ricardo

Chief Transformation Officer

Officer
379 -1.2%
44.47
US$16,854 		379 -1.2% 44.47 US$16,854
2023-08-25 2023-08-24 PlS Planned sale
3.7
Fasman Steven L

EVP & Chief Admin Officer

Officer
817 -1.1%
44.65
US$36,479 		817 -1.1% 44.65 US$36,479
2023-08-24 2023-08-24 PrS Proposed sale
2.6
Lickfold Charles

Officer

Officer
190
44.72
US$8,497 		190 44.72 US$8,497
2023-08-24 2023-08-24 PrS Proposed sale
3.9
Hawkeswood Thomas W

Officer

Officer
147
44.72
US$6,574 		147 44.72 US$6,574
2023-08-24 2023-08-24 PrS Proposed sale
3.7
Fasman Steven L

Officer

Officer
817
44.65
US$36,483 		817 44.65 US$36,483
2023-08-24 2023-08-24 PrS Proposed sale
3.7
Hopson Ricky

Officer

Officer
276
44.56
US$12,299 		276 44.56 US$12,299
2023-08-24 2023-08-24 PrS Proposed sale
3.6
Maselli Alessandro

Officer; Director

Executive Director
2,071
44.54
US$92,248 		2,071 44.54 US$92,248
2023-08-24 2023-08-24 PrS Proposed sale
3.9
Pravda Ricardo

Officer

Officer
379
44.47
US$16,855 		379 44.47 US$16,855
2023-08-24 2023-08-24 PrS Proposed sale
3.7
Grippo Michael J

Officer

Officer
390
44.50
US$17,356 		390 44.50 US$17,356
2023-08-24 2023-08-24 PrS Proposed sale
3.9
Hunt Patricia

Officer

Officer
106
44.77
US$4,746 		106 44.77 US$4,746
2023-08-24 2023-08-24 PrS Proposed sale
4.1
Arnold Jonathan

Officer

Officer
87
44.87
US$3,904 		87 44.87 US$3,904
2023-08-24 2023-08-24 PrS Proposed sale
3.9
Gunther Scott

Officer

Officer
269
44.57
US$11,989 		269 44.57 US$11,989
2023-08-24 2023-08-24 PrS Proposed sale
4.1
Carletti Lorenzo

Officer

Officer
216
44.72
US$9,659 		216 44.72 US$9,659
2023-08-24 2023-08-24 PrS Proposed sale
3.9
Gennadios Aristippos

Officer

Officer
396
44.49
US$17,617 		396 44.49 US$17,617
2023-08-03 2023-08-01 S Sale
3.7
Fasman Steven L

EVP & Chief Admin Officer

Officer
524 -0.9%
47.76
US$25,026 		524 -0.9% 47.76 US$25,026
2023-08-03 2023-08-01 S Sale
3.7
Fasman Steven L

EVP & Chief Admin Officer

Officer
1,113 -1.8%
46.72
US$51,999 		1,113 -1.8% 46.72 US$51,999
2023-08-03 2023-08-01 S Sale
2.6
Lickfold Charles

SVP, CIO

Officer
135 -2.4%
47.90
US$6,466 		135 -2.4% 47.90 US$6,466
2023-08-03 2023-08-01 S Sale
4.1
Arnold Jonathan

SVP, CCO & Div. Head BioP Del.

Officer
62 -0.1%
47.80
US$2,964 		62 -0.1% 47.80 US$2,964
2023-08-03 2023-08-01 S Sale
3.9
Hunt Patricia

Pres. Consumer Health Div

Officer
161 -1.7%
47.95
US$7,720 		161 -1.7% 47.95 US$7,720
2023-08-03 2023-08-01 S Sale
3.9
Pravda Ricardo

Chief Transformation Officer

Officer
222 -1.1%
47.78
US$10,607 		222 -1.1% 47.78 US$10,607
2023-08-03 2023-08-01 S Sale
3.9
Pravda Ricardo

Chief Transformation Officer

Officer
47 -0.2%
46.50
US$2,186 		47 -0.2% 46.50 US$2,186
2023-08-03 2023-08-01 S Sale
3.9
Gennadios Aristippos

Group Pres. Pharma & Consumer

Officer
220 -0.3%
47.87
US$10,531 		220 -0.3% 47.87 US$10,531
2023-08-03 2023-08-01 S Sale
3.9
Gennadios Aristippos

Group Pres. Pharma & Consumer

Officer
61 -0.1%
46.58
US$2,841 		61 -0.1% 46.58 US$2,841
2023-08-03 2023-08-01 S Sale
3.9
Hawkeswood Thomas W

Pres. Pharma Prod Delivery Div

Officer
258 -4.8%
47.97
US$12,376 		258 -4.8% 47.97 US$12,376
2023-08-03 2023-08-01 S Sale
3.9
Gunther Scott

SVP, Quality & Reg. Affairs

Officer
190 -0.8%
47.90
US$9,101 		190 -0.8% 47.90 US$9,101
Explore more

More insider trading research around Catalent Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America